Law firm · United States

Fenwick & West

Deals
21
M&A
18
IPOs
3
Latest
Sep 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

21 of 21 deals

Deals Fenwick & West advised on, most recent first
Advisers
Sep 2026 GoPro ––MergerLegal adviser to GoPro (target)Announced285.0Consumer Electronics+2 Houlihan Lokey (sell-side) Starman Optical and GoPro merger
Aug 2026 FORT Robotics –Newbury Street II Acquisition CorpMergerLegal adviser to FORT Robotics (target)Announced–Robotics+3 BTIG (buy-side)Ellenoff Grossman & Schole (buy-side)Evercore (sell-side)FINN PartnersCollected StrategiesLoeb & Loeb (lead manager) Newbury Street II Acquisition Corp and FORT Robotics merger
Aug 2026 Wisk Aero The Boeing CompanyArcher AviationAsset saleLegal adviser to Archer Aviation (acquirer)Pending–Defence & Aerospace+3 Moelis & Company (buy-side)J.P. Morgan (sell-side)Mayer Brown (sell-side) Archer Aviation acquisition of Wisk Aero
Aug 2026 VitalConnect –iRhythm HoldingsAcquisitionLegal adviser to iRhythm Holdings (acquirer)Announced287.5Medtech Goldman Sachs (buy-side) iRhythm Holdings acquisition of VitalConnect
Aug 2026 Attovia Therapeutics ––IPOLegal adviser to the issuerListed289.0Biotech+1 Morgan Stanley (lead manager)Leerink Partners (lead manager)Citi (lead manager)RBC Capital Markets (lead manager)LifeSci Capital (lead manager)Cooley (lead manager) Attovia Therapeutics IPO
Jul 2026 Anyscale –NscaleAcquisitionLegal adviser to Anyscale (target)Pending–AI+1 Latham & Watkins (buy-side)Goldman Sachs (buy-side)Morgan Stanley (buy-side)Qatalyst Partners (sell-side) Nscale acquisition of Anyscale
Jul 2026 Synlogic ––MergerLegal adviser to Caldera Therapeutics (acquirer)Announced–Biotech+1 Lucid Capital Markets (sell-side)Mintz (sell-side) Caldera Therapeutics and Synlogic merger
Jul 2026 Scribe Therapeutics ––IPOLegal adviser to the issuerListed128.7Biotech+1 Leerink Partners (lead manager)Goldman Sachs (lead manager)Guggenheim Securities (lead manager)Wells Fargo Securities (lead manager)Latham & Watkins (lead manager) Scribe Therapeutics IPO
Jul 2026 Nauto ––MergerLegal adviser to NautoAnnounced–AI+2 BofA Securities Nexar and Nauto merger
Jun 2026 Remix Therapeutics –Passage BioMergerLegal adviser to Passage Bio (acquirer)Pending–Biotech+2 Latham & Watkins (sell-side)Wedbush SecuritiesRBC Capital MarketsCanaccord Genuity Passage Bio and Remix Therapeutics merger
Jun 2026 Vega Therapeutics Star TherapeuticsIncyteAcquisitionLegal adviser to Star Therapeutics (seller)Completed1,250.0Biotech+2 Lazard (buy-side)Goodwin (buy-side)Evercore (sell-side)Morgan Stanley (sell-side) Incyte acquisition of Vega Therapeutics
Jun 2026 Standard BioTools ––MergerLegal adviser to Treeline Biosciences (target)Pending460.0Biotech+2 Centerview Partners (buy-side)Freshfields (buy-side)Richards, Layton & Finger (buy-side)UBS (buy-side)Wedbush Securities (sell-side) Treeline Biosciences and Standard BioTools merger
May 2026 Tonkean –CoupaAcquisitionLegal adviser to Tonkean (target)Announced–Enterprise Software+2 Kirkland & Ellis (buy-side)Cascadia Capital (sell-side) Coupa acquisition of Tonkean
Apr 2026 KalVista Pharmaceuticals –Chiesi GroupAcquisitionLegal adviser to KalVista (target)Completed1,900.0Pharma+2 Lazard (buy-side)Ropes & Gray (buy-side)Centerview Partners (sell-side)Kirkland & Ellis (sell-side)Jefferies (sell-side) Chiesi Group acquisition of KalVista Pharmaceuticals
Apr 2026 Naveris –CareDxAcquisitionLegal adviser to CareDx (acquirer)Announced160.0Diagnostics+1 Goldman Sachs (buy-side)J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side) CareDx acquisition of Naveris
Mar 2026 Day One Biopharmaceuticals –ServierAcquisitionLegal adviser to Day One (target)Pending2,500.0Biotech+2 Goldman Sachs (buy-side)Baker McKenzie (buy-side)Centerview Partners (sell-side)Innisfree M&A (buy-side) Servier acquisition of Day One Biopharmaceuticals
Feb 2026 Pixel Flow! development studio –ScopelyAcquisitionLegal adviser to Pixel Flow! development studio (target)Announced–Video games Skadden, Arps, Slate, Meagher & Flom (buy-side)Hergüner Bilgen Üçer (buy-side) Scopely acquisition of Pixel Flow! development studio
Jan 2026 BitGo Holdings ––IPOLegal adviser to the issuerAnnounced212.8Crypto & Web3 Goldman Sachs (lead manager)Citi (lead manager)Deutsche Bank (lead manager)Mizuho Securities (lead manager)Wells Fargo Securities (lead manager)Keefe, Bruyette & Woods (lead manager)Canaccord Genuity (lead manager)Cantor Fitzgerald (lead manager)Clear Street (lead manager)Compass Point Research & Trading (lead manager)Craig-Hallum (lead manager)Rosenblatt Securities (lead manager)Wedbush Securities (lead manager)SoFi Securities (lead manager)Cravath, Swaine & Moore (lead manager)Whalen LLP (issuer) BitGo Holdings IPO
Jan 2026 Mersana Therapeutics –Day One BiopharmaceuticalsAcquisitionLegal adviser to Day One (acquirer)Completed–Biotech+2 Gordon Dyal & Co. (buy-side)TD Securities (sell-side)WilmerHale (sell-side) Day One Biopharmaceuticals acquisition of Mersana Therapeutics
Sep 2024 Smartsheet –BlackstoneAcquisitionLegal adviser to Smartsheet (target)Completed8,400.0Enterprise Software+1 Qatalyst Partners (sell-side)Goldman Sachs (buy-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)Simpson Thacher & Bartlett (buy-side) Blackstone acquisition of Smartsheet
Apr 2024 Model N –Vista Equity PartnersAcquisitionLegal adviser to Model N (target)Completed1,250.0Vertical SaaS+1 Jefferies (sell-side)Kirkland & Ellis (buy-side)William Blair (buy-side) Vista Equity Partners acquisition of Model N

Activity

Deals by year
Fenwick & West: deals by year2025: 0, 2026 YTD: 190510152020252026 YTD: 16 M&A2026 YTD: 3 Equity raisings192026 YTDM&AEquity raisings

By announcement date; raisings and IPOs by their own date.

Deals by sector
Fenwick & West: deals by sectorBiotech8AI2Enterprise Software2Consumer Electronics1Crypto & Web31Defence & Aerospace1Other sectors6

Sector of the business bought or funded.

Deals by size
Fenwick & West: deals by sizeUS$100–500m7US$1bn+5Undisclosed9

Disclosed value in US dollars.

Most often across the table

Firms advising the other side of the same deals.

Repeat clients

  • Day One2 deals

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.